403 related articles for article (PubMed ID: 11857085)
1. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
3. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
4. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
Andoniou CE; Thien CB; Langdon WY
Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
[TBL] [Abstract][Full Text] [Related]
5. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
[TBL] [Abstract][Full Text] [Related]
6. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
[TBL] [Abstract][Full Text] [Related]
7. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
Salgia R; Sattler M; Pisick E; Li JL; Griffin JD
Exp Hematol; 1996 Feb; 24(2):310-3. PubMed ID: 8641358
[TBL] [Abstract][Full Text] [Related]
8. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
[TBL] [Abstract][Full Text] [Related]
9. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.
Andoniou CE; Thien CB; Langdon WY
EMBO J; 1994 Oct; 13(19):4515-23. PubMed ID: 7925293
[TBL] [Abstract][Full Text] [Related]
10. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
11. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
[TBL] [Abstract][Full Text] [Related]
12. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
13. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
Sattler M; Salgia R; Shrikhande G; Verma S; Uemura N; Law SF; Golemis EA; Griffin JD
J Biol Chem; 1997 May; 272(22):14320-6. PubMed ID: 9162067
[TBL] [Abstract][Full Text] [Related]
14. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
Ribon V; Hubbell S; Herrera R; Saltiel AR
Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
[TBL] [Abstract][Full Text] [Related]
15. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.
Zhang Z; Elly C; Qiu L; Altman A; Liu YC
Curr Biol; 1999 Feb; 9(4):203-6. PubMed ID: 10074432
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts.
Feshchenko EA; Shore SK; Tsygankov AY
Oncogene; 1999 Jun; 18(25):3703-15. PubMed ID: 10391678
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.
Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ
Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908
[TBL] [Abstract][Full Text] [Related]
18. Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.
Sattler M; Salgia R
Cytokine Growth Factor Rev; 1997 Mar; 8(1):63-79. PubMed ID: 9174663
[TBL] [Abstract][Full Text] [Related]
19. c-CBL is not required for leukemia induction by Bcr-Abl in mice.
Dinulescu DM; Wood LJ; Shen L; Loriaux M; Corless CL; Gross AW; Ren R; Deininger MW; Druker BJ
Oncogene; 2003 Dec; 22(55):8852-60. PubMed ID: 14654781
[TBL] [Abstract][Full Text] [Related]
20. Adapting to multiple personalities: Cbl is also a RING finger ubiquitin ligase.
Sawasdikosol S; Pratt JC; Meng W; Eck MJ; Burakoff SJ
Biochim Biophys Acta; 2000 Jul; 1471(1):M1-M12. PubMed ID: 11004605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
